Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Zentalis Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 123 institutions reported holding Zentalis Pharmaceuticals, Inc., 69.0% of its shares. Largest: Squadron Capital Management LLC, Vanguard and Citadel. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Zentalis Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Squadron Capital Management LLC | 6.83M | 6.9% | +3.13M | Nov 16, 2026 |
| Vanguard | 5.2M | 5.3% | +1.19M | Nov 13, 2026 |
| Citadel | 4.49M | 4.6% | +2.19M | Nov 16, 2026 |
| 5AM Venture Management, LLC | 3.95M | 4.0% | no change | Nov 16, 2026 |
| BlackRock | 3.91M | 4.0% | +159K | Nov 13, 2026 |
| ADAR1 Capital Management, LLC | 3.76M | 3.8% | +3.11M | Nov 16, 2026 |
| NEA Management Company, LLC | 3.57M | 3.6% | new | Nov 20, 2026 |
| Acadian Asset Management LLC | 3.06M | 3.1% | +374K | Nov 9, 2026 |
| Two Sigma | 2.8M | 2.9% | −224K | Nov 16, 2026 |
| Patient Square Capital LP | 2.01M | 2.0% | new | Nov 10, 2026 |